On Monday, CorMedix Inc (NASDAQ: CRMD) was 3.79% up from the session before settling in for the closing price of $11.60. A 52-week range for CRMD has been $2.57 – $13.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -47.11% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 45.05%. With a float of $59.73 million, this company’s outstanding shares have now reached $60.68 million.
In an organization with 82 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 94.0%, operating margin of -29.11%, and the pretax margin is -24.63%.
CorMedix Inc (CRMD) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward CorMedix Inc stocks. The insider ownership of CorMedix Inc is 1.56%, while institutional ownership is 31.09%. The most recent insider transaction that took place on Mar 13 ’24, was worth 50,718. In this transaction Chief Executive Officer of this company bought 13,561 shares at a rate of $3.74, taking the stock ownership to the 352,839 shares. Before that another transaction happened on Dec 14 ’23, when Company’s Director bought 3,000 for $3.45, making the entire transaction worth $10,350. This insider now owns 12,250 shares in total.
CorMedix Inc (CRMD) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.26 earnings per share (EPS) during the time that was less than consensus figure (set at -0.2) by -0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 45.05% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
You can see what CorMedix Inc (CRMD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 65.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.36 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
Let’s dig in a bit further. During the last 5-days, its volume was 1.26 million. That was better than the volume of 0.72 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 55.03%. Additionally, its Average True Range was 0.81.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 82.32%, which indicates a significant increase from 59.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 124.98% in the past 14 days, which was higher than the 82.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.10, while its 200-day Moving Average is $5.66. However, in the short run, CorMedix Inc’s stock first resistance to watch stands at $12.46. Second resistance stands at $12.87. The third major resistance level sits at $13.35. If the price goes on to break the first support level at $11.57, it is likely to go to the next support level at $11.09. The third support level lies at $10.68 if the price breaches the second support level.
CorMedix Inc (NASDAQ: CRMD) Key Stats
There are 60,677K outstanding shares of the company, which has a market capitalization of 797.22 million. As of now, sales total 0 K while income totals -46,340 K. Its latest quarter income was 11,460 K while its last quarter net income were -2,780 K.
